A Cost‑Utility Analysis of Add‑On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales

Mar-24

Database Pharmacoepidemiology

AUTHORS : Colin Burke, Lumanity, Inc, Great Suffolk Yard, 121-131 Great Suffolk Street, London, SE1 1PP, UK EMAIL; Colin.Burke@lumanity.com

JOURNAL : PharmacoEconomics- Open

REFERENCE:

DOI : 10.1007/s41669-024-00474-x

Read more